✦ LIBER ✦

Views on methods for monitoring recombinant factor VIIa in inhibitor patients

✍ Scribed by Nigel S Key; Gary L Nelsestuen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylactic recombinant factor VIIa in

✍ G. Young; M. McDaniel; D. J. Nugent 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

High-Dose Recombinant Factor VIIa Therap

✍ Gili Kenet 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Successful use of recombinant factor VII

✍ G. DELIOS; B. POLLIO; M. TUCCIARONE; G. AITORO; A. BORCHIELLINI; P. SCHINCO; M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Control of haemostasis with recombinant

✍ Ingerslev, Jrgen; Feldstedt, Mathilde; Sindet-Pedersen, Steen 📂 Article 📅 1991 🏛 The Lancet 🌐 English ⚖ 325 KB

Monitoring low dose recombinant factor V

✍ Riddell, A.; Abdul-Kadir, R.; Pollard, D.; Tuddenham, E.; Gomez, K. 📂 Article 📅 2011 🏛 Schattauer 🌐 English ⚖ 405 KB

Randomized, prospective clinical trial o

✍ B. A. KONKLE; L. S. EBBESEN; E. ERHARDTSEN; R. P. BIANCO; T. LISSITCHKOV; L. RUS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB